COLL vs TROW · P/E 17, rev $181.9M vs P/E 12, rev $7.09B
Collegium Pharmaceutical Inc (COLL) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the COLL and TROW stock pages for the full models.
Not investment advice.